Information  X 
Enter a valid email address

Valirx PLC Ord 0.1P (VAL)

Date Time Source Announcement
25 Sep 2018 7:00 am
RNS
Half-year Report
14 Sep 2018 12:42 pm
RNS
Issue of Equity
06 Sep 2018 7:00 am
RNS
Update on Clinical Development
24 Jul 2018 12:17 pm
RNS
Result of General Meeting
17 Jul 2018 7:00 am
RNS
US PATENT GRANT FOR THERAPEUTIC COMPOUND, VAL301
06 Jul 2018 4:42 pm
RNS
Notice of GM
14 Jun 2018 7:00 am
RNS
VAL401 Update
24 May 2018 9:00 am
RNS
Price Monitoring Extension
11 May 2018 2:56 pm
RNS
Holding(s) in Company
08 May 2018 12:13 pm
RNS
Result of AGM
04 May 2018 4:40 pm
RNS
Second Price Monitoring Extn
  4:35 pm
RNS
Price Monitoring Extension
  4:01 pm
RNS
Placing and grant of warrants
26 Apr 2018 2:05 pm
RNS
Second Price Monitoring Extn
  2:00 pm
RNS
Price Monitoring Extension
25 Apr 2018 4:40 pm
RNS
Second Price Monitoring Extn
  4:35 pm
RNS
Price Monitoring Extension
  7:00 am
RNS
EU Patent Grant for Therapeutic Compound, VAL201
20 Apr 2018 10:43 am
EQS
ValiRx (VAL): 2017: a pivotal year
19 Apr 2018 7:00 am
RNS
GENEICE & VAL101 Update
12 Apr 2018 7:00 am
RNS
Notice of AGM
10 Apr 2018 7:00 am
RNS
Final Results
20 Mar 2018 7:00 am
RNS
US Patent Grant for Therapeutic Compound, VAL201
19 Mar 2018 7:00 am
RNS
Holding(s) in Company
16 Mar 2018 3:01 pm
RNS
Appointment of Broker
02 Mar 2018 11:01 am
RNS
Statement re broker
09 Feb 2018 11:57 am
RNS
Issue of options and directors dealings
02 Feb 2018 4:26 pm
RNS
Holding(s) in Company
25 Jan 2018 12:06 pm
RNS
Holding(s) in Company
23 Jan 2018 3:30 pm
RNS
Holding(s) in Company
16 Jan 2018 7:00 am
RNS
ValiSeek Clinical Update (VAL401)
11 Jan 2018 7:00 am
RNS
US Patent Notice of Allowance for Compound VAL201
04 Jan 2018 2:29 pm
RNS
Holding(s) in Company
03 Jan 2018 7:00 am
RNS
Exercise of Warrants and Issue of Equity
27 Dec 2017 12:54 pm
RNS
Final Loan Note Conversion and Issue of Equity
22 Dec 2017 7:00 am
RNS
Issue of Equity
21 Dec 2017 9:16 am
RNS
Result of General Meeting
20 Dec 2017 3:58 pm
RNS
Warrant Exercise
  3:03 pm
RNS
Warrant Exercise
18 Dec 2017 8:45 am
RNS
Warrant Exercise
  7:00 am
RNS
re: VAL201 Clinical Trials
15 Dec 2017 7:00 am
RNS
Exercise of Warrants and Issue of Equity
12 Dec 2017 7:00 am
RNS
ValiSeek Clinical Development Update
11 Dec 2017 3:48 pm
RNS
Loan Note Conversion and Issue of Equity
06 Dec 2017 7:00 am
RNS
Shareholder Circular and Notice of General Meeting
30 Nov 2017 2:38 pm
RNS
Issue of Equity
20 Nov 2017 11:23 am
RNS
Holding(s) in Company
15 Nov 2017 4:37 pm
RNS
Yorkville CLN Conversion
11 Oct 2017 7:00 am
RNS
Notification of US Patent Allowance
05 Oct 2017 7:00 am
RNS
Holding(s) in Company
02 Oct 2017 7:00 am
RNS
Total Voting Rights
28 Sep 2017 7:00 am
RNS
ValiSeek Clinical Development Update
27 Sep 2017 3:32 pm
RNS
Holding(s) in Company
26 Sep 2017 7:00 am
RNS
Half-year Report
20 Sep 2017 3:18 pm
RNS
VAL201 update
19 Sep 2017 7:00 am
RNS
Issue of Equity
13 Sep 2017 9:34 am
RNS
Hardman Research: GeneICE and VAL101 progress
07 Sep 2017 7:00 am
RNS
GeneICE & VAL101 Update
11 Aug 2017 7:00 am
RNS
Convertible Loan Facility
02 Aug 2017 7:00 am
RNS
Conversion of Loan Note
 
Headlines
Top categories
Company finder

a d v e r t i s e m e n t